Overview
| Dividend | 0.24 |
| Ex-Dividend Date | Jan 13, 2023 |
| Annualized Return (1Y) | -26.52% |
| Annualized Return (3Y) | 19.79% |
| Annualized Return (5Y) | -11.48% |
| Annualized Return (10Y) | -25.89% |
| Annualized Return (15Y) | -39.54% |
| Volume | 81,592 |
| Close | 5.93 |
| Previous Close | 6.06 |
| Worst 3Y Roll AR | -78.59% |
| Worst 5Y Roll AR | -64.24% |
| Worst 10Y Roll AR | -53.69% |
| Worst 15Y Roll AR | -42.76% |
| Inception Date | Apr 12, 2006 |
Dividends
Gyre Therapeutics Inc. (GYRE) Dividend Information
Gyre Therapeutics Inc. (GYRE) dividend growth in the last 12 months is
The trailing 12-month yield of Gyre Therapeutics Inc. is 0.00%. Its dividend history:
| Pay Date | Cash Amount |
|---|---|
| Jan 13, 2023 | $0.24 |
| Sep 21, 2022 | $1.43 |
Gyre Therapeutics Inc. (GYRE) Dividend Calculator
Dividend Growth History for Gyre Therapeutics Inc. (GYRE)
|
Year
|
Payout Amount
|
Year Start Yield
|
Annual Payout Growth (YoY)
|
CAGR to 2023
|
|---|---|---|---|---|
| 2023 | $0.24 | 40.68% | -83.22% | - |
| 2022 | $1.43 | 143.00% | - | -83.22% |
Dividend Growth Chart for Gyre Therapeutics Inc. (GYRE)
Performance
Gyre Therapeutics Inc. (GYRE) Historical Returns And Risk Info
From 04/12/2006 to 06/12/2026, the compound annualized total return (dividend reinvested) of Gyre Therapeutics Inc. (GYRE) is -28.018% . Its cumulative total return (dividend reinvested) is -99.866% .
From 04/12/2006 to 06/12/2026, the Maximum Drawdown of Gyre Therapeutics Inc. (GYRE) is 100.0%.
From 04/12/2006 to 06/12/2026, the Sharpe Ratio of Gyre Therapeutics Inc. (GYRE) is -0.28.
From 04/12/2006 to 06/12/2026, the Annualized Standard Deviation of Gyre Therapeutics Inc. (GYRE) is 104.7%.
From 04/12/2006 to 06/12/2026, the Beta of Gyre Therapeutics Inc. (GYRE) is 1.46.
| Name | YTD Return | 1Yr AR | 3Yr AR | 5Yr AR | 10Yr AR | 15Yr AR | 20Yr AR | Common | Inception |
|---|---|---|---|---|---|---|---|---|---|
| GYRE (Gyre Therapeutics Inc.) | -16.01% | -26.52% | 19.79% | -11.48% | -25.89% | -39.54% | -27.50% | ... | ... |
| VTSMX (VANGUARD TOTAL STOCK MARKET INDEX FUND INVESTOR SHARES) | 9.64% | 24.74% | 20.80% | 12.06% | 14.88% | 13.97% | 11.21% | ... | ... |
Return Calculator for Gyre Therapeutics Inc. (GYRE)
Start date (MM/dd/yyyy)
End date (MM/dd/yyyy)
Gyre Therapeutics Inc. (GYRE) Historical Return Chart
Calculators
Dollar Cost Average Calculator for Gyre Therapeutics Inc. (GYRE)
Retirement Spending Calculator for Gyre Therapeutics Inc. (GYRE)
Rolling Returns
A rolling return for a period such as 5-year, as of a specific date, represents the investment’s performance over the preceding five years leading up to that date. In the 5-year rolling chart, the value on any given date corresponds to the annualized return for the preceding 5 years up to that very date. Thus, for instance, the chart value on 8/28/2015 reflects the annualized return from 8/28/2010 to 8/28/2015. A 5-year rolling return chart for an investment (stock, fund or portfolio) depicts the return sequence of 5-year trailing returns for the dates in the chart.
These rolling returns contrast with the most recent 3, 5, 10, and 15-year returns, as they solely depict the returns for those respective periods leading up to the most recent date, without encompassing every date in the historical record.
Rolling return charts offer a more precise insight into a portfolio’s risk and return stability (including funds or individual stocks). This is particularly true when focusing on the minimal return points within a rolling return chart as a measure of a fund or a portfolio's risk. A well-known observation, often attributed to ‘Murphy’s law’, is that it tends to perform poorly when investors decide to follow an investment due to its recent strong returns. Sound familiar? Information regarding minimum rolling returns could help mitigate this predicament. Investors can opt for an investment showcasing high minimum rolling returns within their preferred holding durations. In fact, merely possessing knowledge of such minimum rolling period returns can anchor investors’ expectations.
For instance, let’s consider an investor who follows a model portfolio (or even simply purchases and holds a fund like VFINX or SPY) for 10 years. Armed with knowledge of this portfolio’s minimum 10-year rolling return since its inception date or the fund’s inception (in the case of VFINX, recognizing that the minimum 10-year rolling return since 1987 could be as low as -2.24%), the investor should reasonably anticipate the potential for the portfolio to incur losses over the forthcoming 10 years.
Minimum rolling return for a period such as 10-year offers a different and often better historical risk and return metric than other popular risk and return metrics such as Sharpe ratio, standard deviation (volatility) or maximum drawdown.
See Portfolio Calculator and Rolling Returns for more detailed description.
Drawdowns
Gyre Therapeutics Inc. (GYRE) Maximum Drawdown
Related Articles for Gyre Therapeutics Inc.(GYRE)
